(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Hummingbird Resources PLC - gold production, development and exploration focused on West Africa - Exercises its right to convert its 51% interest in the Dugbe Gold Project to a 51% interest in Pasofino, so that Pasofino would become the owner of 100% of Dugbe. "With this consolidation, Hummingbird moves to owning 51% of Pasofino which simplifies the ownership structure and ensures that what is one of the largest gold projects in West Africa has clear visibility of its own," Chief Executive Dan Betts says.
----------
Ironveld PLC - South Africa-focused exploration and development company - Says its subsidiary Ironveld Smelting Proprietary Ltd signed a share purchase agreement to acquire 100% of the share capital of Ferrochrome Furnaces Pty Ltd. It is purchasing ZAR115 million, or GBP5.5 million, of debt from the sole creditor of FCF.
----------
OptiBiotix Health PLC - York-based probiotics developer tackling cardiovascular diseases and lifestyle conditions - Launches GoFigure shakes that contain patented weight management aid SlimBiome on Tmall China. Tmall is a cross-border marketplace. "I am very pleased with the launch of our own Tmall store and that we can now focus on getting the GoFigure range direct to the Chinese consumer," CEO Rene Kamminga comments.
----------
Rosslyn Data Technologies PLC - Portsmouth, England-based data management and analytics service provider - Sells its trade and software assets related to its Integritie business for a total of GBP3.0 million. This consists of an initial cash consideration of GBP1.6 million and a GBP1.4 million conditional deferred payment based on achieving certain revenue and growth targets. "We are pleased to have completed our divestment plans with the sale of Langdon Systems last month and now Integritie. This will enable us to focus our resources on our core product - the upgraded Rosslyn spend analytics platform - as well as reduce our cash burn," CEO Paul Watts says.
----------
Dukemount Capital PLC - investor in the sustainable and flexible energy markets - Requests for its shares to be suspended until the audit of its results for the year which ended April 30 can be completed. Once completed the company will apply for its shares to be unsuspended and to start trading, it states.
----------
Made.com Group PLC - London-based furniture retailer - Reiterates that all potential buyers confirmed that they were unable to meet the necessary timetable. Resolves to file a notice of its intention to appoint administrators. Views to appoint Zelf Hussain, Peter David Dickens and Rachael Maria Wilkinson of PricewaterhouseCoopers LLP as administrators of MDL. Requests the suspension of its shares. Expects shares to be cancelled and value to be distributed to shareholders.
----------
Diaceutics PLC - Belfast-based testing laboratories company - Notes that a large-scale study highlighted that a "significant number" of eligible patients treated for lung cancer did not receive access to the medicines most suitable to them. The study examined deidentified Medicare claims and laboratory data from 38,068 US-based patients diagnosed with advanced non-small cell lung cancer in 2019, it continues. "More than ever, there is an urgent need for greater investment and a multi-stakeholder approach across labs, healthcare professionals and policy makers to ensure the significant benefits of personalised medicine are more widely felt. Diaceutics' proprietary DXRX platform is ideally placed to provide the core data to catalyse this collaborative approach," CEO Peter Keelings says.
----------
Alternative Income REIT PLC - London-based real estate investment company - Net asset value per share as at September 30 stands at 97.0 pence, up 0.6% versus 96.4p as at June 30. Share price on the same date falls 21% to 65.3p from 82.1p in the period. Records a NAV total return of 2.3% from 5.2% in the previous quarter. Says its portfolio has continued to show resilience, with a slight overall increase in capital values. Declares an interim quarterly dividend of 1.375p per share for the third quarter ended September 30.
----------
Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Says its subsidiary Tetris Pharma Ltd launched Ogluo in Germany as a treatment for severe hypoglycaemia in children and adults living with diabetes. Hypoglycaemia is an abnormally low level of blood sugar. "With the launch of Ogluo in Germany, Tetris Pharma has achieved a significant milestone through the commercialisation of our flagship product," Managing Director Shafiq Choudhary comments.
----------
AssetCo PLC - London-based advisory and asset management firm - Reaches an agreement to acquire the entire issued share capital of SVM Asset Management Holdings Ltd. Says the consideration payable was GBP11.2 million after balance sheet adjustments. "The completion of the acquisition of SVM is part of AssetCo's overall strategy of investing in, building and managing asset and wealth management businesses," Chair Martin Gilbert comments.
----------
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
